Tech Company Financing Transactions
Abreos Biosciences Funding Round
Triton Technology Fund participated in a Seed venture round for Abreos Biosciences. The funding round was announced on 6/29/2016.
Transaction Overview
Company Name
Announced On
6/29/2016
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Triton Technology Fund (Dave Schwab)
Proceeds Purpose
Funds from the seed round are enabling Abreos to accelerate their commercialization plan, expand their marketing and business development teams, and establish major clinical research partnerships in the US and Europe.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2223 Avenida de la Playa 206
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
Abreos Biosciences is an early stage biotech company pioneering assays for detection of biologic drugs using its proprietary Veritope technology. Abreos develops laboratory-based and point-of-care assays that enable personalized dosing and counterfeit detection of these expensive drugs, such as therapeutic monoclonal antibodies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bradley Messmer
Chief Operating Officer
Michael Little
Browse more venture capital transactions:
Prev: 6/29/2016: Crowded.com venture capital transaction
Next: 6/29/2016: PredictSpring venture capital transaction
Share this article
News on VC Transactions
We report on funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs